
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Establishment of the Prognosis Predicting Signature for Endometrial Cancer Patient
Jia Tang, Wei Ma, Liangping Luo
Medical Science Monitor (2019) Vol. 25, pp. 8248-8259
Open Access | Times Cited: 8
Jia Tang, Wei Ma, Liangping Luo
Medical Science Monitor (2019) Vol. 25, pp. 8248-8259
Open Access | Times Cited: 8
Showing 8 citing articles:
Development of a novel immune-related lncRNA signature as a prognostic classifier for endometrial carcinoma
Jinhui Liu, Jie Mei, Yichun Wang, et al.
International Journal of Biological Sciences (2021) Vol. 17, Iss. 2, pp. 448-459
Open Access | Times Cited: 30
Jinhui Liu, Jie Mei, Yichun Wang, et al.
International Journal of Biological Sciences (2021) Vol. 17, Iss. 2, pp. 448-459
Open Access | Times Cited: 30
miR-193a-3p inhibition of the Slug activator PAK4 suppresses non-small cell lung cancer aggressiveness via the p53/Slug/L1CAM pathway
Xincheng Liu, Shengping Min, Nan Wu, et al.
Cancer Letters (2019) Vol. 447, pp. 56-65
Closed Access | Times Cited: 34
Xincheng Liu, Shengping Min, Nan Wu, et al.
Cancer Letters (2019) Vol. 447, pp. 56-65
Closed Access | Times Cited: 34
Development of an immune gene prognostic classifier for survival prediction and respond to immunocheckpoint inhibitor therapy/chemotherapy in endometrial cancer
Jinhui Liu, Xing Chen, Yi Jiang, et al.
International Immunopharmacology (2020) Vol. 86, pp. 106735-106735
Closed Access | Times Cited: 25
Jinhui Liu, Xing Chen, Yi Jiang, et al.
International Immunopharmacology (2020) Vol. 86, pp. 106735-106735
Closed Access | Times Cited: 25
MicroRNA as Epigenetic Modifiers in Endometrial Cancer: A Systematic Review
Amélia Favier, G Röcher, Annette K. Larsen, et al.
Cancers (2021) Vol. 13, Iss. 5, pp. 1137-1137
Open Access | Times Cited: 23
Amélia Favier, G Röcher, Annette K. Larsen, et al.
Cancers (2021) Vol. 13, Iss. 5, pp. 1137-1137
Open Access | Times Cited: 23
Identification of methylation-driven genes prognosis signature and immune microenvironment in uterus corpus endometrial cancer
Jinhui Liu, Chengjian Ji, Yichun Wang, et al.
Cancer Cell International (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 17
Jinhui Liu, Chengjian Ji, Yichun Wang, et al.
Cancer Cell International (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 17
The optimal cut‐off value of immunohistochemical parameter P53 for predicting recurrence of endometrial cancer
Mingzhu Jia, Peng Jiang, Jing Hu, et al.
International Journal of Gynecology & Obstetrics (2020) Vol. 153, Iss. 2, pp. 344-350
Closed Access | Times Cited: 12
Mingzhu Jia, Peng Jiang, Jing Hu, et al.
International Journal of Gynecology & Obstetrics (2020) Vol. 153, Iss. 2, pp. 344-350
Closed Access | Times Cited: 12
Low Expression of miR-375 and miR-190b Differentiates Grade 3 Patients with Endometrial Cancer
Miłosz Pietrus, Michał Seweryn, Przemysław Kapusta, et al.
Biomolecules (2021) Vol. 11, Iss. 2, pp. 274-274
Open Access | Times Cited: 4
Miłosz Pietrus, Michał Seweryn, Przemysław Kapusta, et al.
Biomolecules (2021) Vol. 11, Iss. 2, pp. 274-274
Open Access | Times Cited: 4
Epigenetic signatures and prognostic biomarkers analysis of methylation-driven genes in uterine endometrial carcinosarcoma
Na Zhang, Wangshu Li, Fang Wang, et al.
Critical Reviews in Eukaryotic Gene Expression (2024) Vol. 35, Iss. 2, pp. 27-47
Closed Access
Na Zhang, Wangshu Li, Fang Wang, et al.
Critical Reviews in Eukaryotic Gene Expression (2024) Vol. 35, Iss. 2, pp. 27-47
Closed Access